Boehringer Ingelheim (BI)
has announced the 01 Dec funding
of the first tiotropium-based
combination therapy on the
Pharmaceutical Benefits Scheme
for the treatment of chronic
obstructive pulmonary disease.
Spiolto Respimat combines 5μg of
tiotropium and 5μg of olodaterol in
the Respimat Soft Mist inhaler.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.